Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass

with No Comments

Vancouver, BC – October 20th, 2021 / Creatus Biosciences Inc. (“Creatus”) have signed a purchase agreement with Virdia, LLC (“Virdia”), a wholly-owned subsidiary of Stora Enso Oyj (“Stora Enso”) to commercialize end-to-end production of xylitol by fermentation from biomass. The agreement sees Creatus acquire the exclusive option to all IP assets of Virdia’s technology platform, which converts lignocellulosic biomass to high quality fermentable sugars and lignin.… Read More